###begin article-title 0
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
MiR-24 Tumor Suppressor Activity Is Regulated Independent of p53 and through a Target Site Polymorphism
###end article-title 0
###begin p 1
Conceived and designed the experiments: PM RH DB GM JJ JB. Performed the experiments: PM BS PJM. Analyzed the data: PM BS YW RH JJ. Wrote the paper: PM JB.
###end p 1
###begin p 2
###xml 192 198 192 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 379 385 379 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 492 498 492 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 626 632 626 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 731 737 731 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 815 821 815 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 1022 1028 1022 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 1093 1099 1093 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 1270 1276 1270 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 1371 1377 1371 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 1400 1406 1400 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 1295 1300 <span type="species:ncbi:9606">human</span>
MicroRNAs (miRNAs) are predicted to regulate approximately 30% of all human genes; however, only a few miRNAs have been assigned their targets and specific functions. Here we demonstrate that miR-24, a ubiquitously expressed miRNA, has an anti-proliferative effect independent of p53 function. Cell lines with differential p53 status were used as a model to study the effects of miR-24 on cell proliferation, cell cycle control, gene regulation and cellular transformation. Overexpression of miR-24 in six different cell lines, independent of p53 function, inhibited cell proliferation and resulted in G2/S cell cycle arrest. MiR-24 over expression in cells with wt-p53 upregulated TP53 and p21 protein; however, in p53-null cells miR-24 still induced cell cycle arrest without the involvement of p21. We show that miR-24 regulates p53-independent cellular proliferation by regulating an S-phase enzyme, dihydrofolate reductase (DHFR) a target of the chemotherapeutic drug methotrexate (MTX). Of interest, we found that a miR-24 target site polymorphism in DHFR 3' UTR that results in loss of miR-24-function and high DHFR levels in the cell imparts a growth advantage to immortalized cells and induces neoplastic transformation. Of clinical significance, we found that miR-24 is deregulated in human colorectal cancer tumors and a subset of tumors has reduced levels of miR-24. A novel function for miR-24 as a p53-independent cell cycle inhibitory miRNA is proposed.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 257 260 257 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-LagosQuintana1">[1]</xref>
###xml 261 264 261 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Baek1">[5]</xref>
###xml 435 438 435 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra1">[6]</xref>
###xml 760 763 760 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Calin1">[7]</xref>
###xml 764 767 764 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Calin2">[9]</xref>
###xml 867 870 867 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Calin1">[7]</xref>
###xml 305 310 <span type="species:ncbi:9606">human</span>
MicroRNAs (miRNAs) are small non-coding RNAs, processed from longer transcripts by Drosha and Dicer, that mostly bind to the 3' untranslated regions (3'UTR) of target genes and inhibit gene expression translationally and/or by destabilizing the target mRNA [1]-[5]. As miRNA expression is altered in many human diseases, including cancer, the discovery of miRNAs has added an entirely new dimension to antitumor therapeutic approaches [6]. Although a few miRNAs are overexpressed in cancer and seem to function as oncogenes themselves (miR-17-92, miR-155), a greater number of miRNAs have been shown to be down-regulated in cancer and have the potential to act as tumor suppressors (i.e., Let-7, miR-15/miR-16, miR-1/miR-206, miR-29, miR-124, miR-143/miR-145) [7]-[9]. Hence miRNAs are differentially expressed in many cancers and play a critical role in oncogenesis [7].
###end p 4
###begin p 5
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Lewis1">[10]</xref>
###xml 167 173 167 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 242 249 242 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008445.s001">Fig. S1</xref>
###xml 252 258 252 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Gibcus1">[11]</xref>
###xml 381 387 381 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 455 461 455 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 545 549 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Lal1">[12]</xref>
###xml 597 601 597 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Neilson1">[13]</xref>
###xml 651 655 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Sun1">[14]</xref>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Fukuda1">[15]</xref>
###xml 663 669 663 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 757 761 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Gammell1">[16]</xref>
###xml 822 826 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Tzur1">[17]</xref>
###xml 828 834 828 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 886 890 886 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Gibcus2">[18]</xref>
###xml 910 916 910 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 962 966 962 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Cheng1">[19]</xref>
###xml 968 974 968 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 1078 1082 1078 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Wang1">[20]</xref>
###xml 1084 1088 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Lal2">[21]</xref>
###xml 73 78 <span type="species:ncbi:9606">human</span>
Although miRNAs have been predicted to regulate approximately 30% of all human genes, few miRNAs have been assigned to their target mRNAs and specific functions [10]. MiR-24 is an abundant miRNA and is well conserved between various species (Fig. S1). MiR-24 is expressed in normal tissues such as adipose tissue, mammary gland, kidney and in differentiated skeletal muscles [11]. MiR-24 is found to be upregulated in differentiated cells. High levels of miR-24 have been reported during post-mitotic differentiation of hematopoietic cell lines [12], during thymic development to naive CD8T cells [13] and during myoblast and neuronal differentiation [14], [15]. MiR-24 was also found to be upregulated during the stationary phase of growth in CHO-K1 cells [16], and in sodium butyrate differentiated embryonic stem cells [17]. MiR-24 is also deregulated in Hodgkin lymphoma cell lines [18], and inhibition of miR-24 in Hela cells markedly increased cell growth [19]. MiR-24 also plays a role in erythropoiesis by regulating ALK4 and in replicative senescence by regulating p16 [20], [21].
###end p 5
###begin p 6
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 86 93 86 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-23b</italic>
###xml 95 115 95 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-27b and miR-24-1</italic>
###xml 150 157 150 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-23a</italic>
###xml 159 166 159 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-27a</italic>
###xml 171 179 171 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-2</italic>
###xml 247 250 247 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Calin2">[9]</xref>
###xml 258 264 258 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 325 331 325 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 390 396 390 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 447 453 447 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 454 457 454 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNP</italic>
###xml 477 483 477 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 592 596 592 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra2">[22]</xref>
###xml 631 637 631 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 754 758 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Lal3">[23]</xref>
MiR-24 clusters with two other miRNAs, miR-23 and miR-27, on chromosome 9 (cluster-1: miR-23b, miR-27b and miR-24-1) and on chromosome 19 (cluster-1: miR-23a, miR-27a and miR-24-2). Deregulations at both sites were found to be associated with CLL [9]. Since miR-24 is associated with differentiation, we explored the role of miR-24 in cellular transformation. We have previously shown that miR-24 has a target site in the 3'UTR of DHFR mRNA and a miR-24-SNP results in loss of miR-24-mediated inhibition of DHFR, in MTX resistance, and is associated with an increase in DHFR mRNA and protein [22]. A recent report also showed that miR-24 suppressed the expression of cell cycle control genes E2F2 and Myc via binding to 3'-UTR miRNA recognition elements [23].
###end p 6
###begin p 7
###xml 82 88 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 190 196 190 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 320 326 320 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 380 393 378 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 433 439 431 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 623 629 621 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 719 725 717 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 648 653 <span type="species:ncbi:9606">human</span>
In this study we used mutant and wild type p53 cell lines to study the effects of miR-24 on cell proliferation and cell cycle control and their mechanisms of regulation. We demonstrate that miR-24 regulates cellular proliferation, independent of p53 function, by regulating DHFR expression. Of interest, we found that a miR-24 target site (TS) SNP 829C-->T (hereafter referred as miR-24-TS-SNP) in the DHFR 3' UTR results in loss of miR-24-function and high DHFR levels in the cell, and imparts a growth advantage to immortalized cells and induces neoplastic transformation. Of possible clinical significance, we find that miR-24 is deregulated in human colorectal cancers, and subsets of tumors have reduced levels of miR-24.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
MiR-24 overexpression, independent of p53-function, inhibits anchorage dependent cellular proliferation and induces G2/S arrest
###end title 9
###begin p 10
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 50 57 50 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008445.s001">Fig. S1</xref>
###xml 101 107 101 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 395 398 395 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR</italic>
###xml 449 455 449 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 542 551 542 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g001">Fig. 1A&#8211;G</xref>
###xml 647 650 647 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR</italic>
###xml 708 714 708 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 764 770 764 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 203 208 <span type="species:ncbi:9606">human</span>
###xml 314 319 <span type="species:ncbi:9606">human</span>
MiR-24 is a highly conserved miRNA among species (Fig. S1). To assess the functional significance of miR-24, we evaluated its effect on cellular proliferation using six different cancer cell lines; four human colon cancer cell lines [HCT-116 (wt-p53), HCT-116 (null-p53), RKO (wt-p53) and HT-29 (mut-p53)] and two human osteosarcoma cell lines [U2OS (wt-p53) and MG63 (null-p53)]. A nonspecific miR was used as a negative control. Overexpression of miR-24 suppressed cellular proliferation in all of the cell lines independent of p53 status (Fig. 1A-G) (p<0.05, standard deviations are plotted as error bars on the graph). The nonspecific control miR had no effect on cellular proliferation, suggesting that miR-24 mediated inhibition of cellular proliferation is miR-24-specific.
###end p 10
###begin title 11
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
MiR-24 inhibits anchorage-dependent cell proliferation independent of p53 status in six different cancer cell lines.
###end title 11
###begin p 12
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 239 245 239 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 283 289 283 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 526 532 526 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
(A) Morphological changes after the non-specific control-miR and miR-24 over expression in HCT-116 (wt-p53) is demonstrated. (B-G) Six different cancer cell lines, with or without functional p53, were transfected with control miR (neg) or miR-24 and cell number was determined. Upon miR-24 transfection cell proliferation was inhibited approximately from 30% to 65% at day 5 as compared to the control (p<0.05, standard deviations are plotted as error bars on the graphs). Of interest, regardless of the p53 status of a cell, miR-24 inhibited cell proliferation.
###end p 12
###begin p 13
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 118 124 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 265 268 265 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR</italic>
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 280 286 280 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 302 303 302 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 350 360 350 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g002">Fig. 2A, B</xref>
###xml 423 429 423 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g001">Fig. 1</xref>
###xml 447 453 447 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
We next determined if the effect of miR-24 on cellular proliferation was related to cell cycle control. The effect of miR-24 on the cell cycle was analyzed by flow cytometry using HCT-116 (wt-p53) and HCT-116 (null-p53) cells transfected with a nonspecific control miR or miR-24. MiR-24 increased the G2-S ratio in both colorectal cancer cell lines (Fig. 2A, B). This finding, together with the cell proliferation results (Fig. 1), confirmed that miR-24 mediated inhibition of the cell-cycle is independent of p53 function.
###end p 13
###begin title 14
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
MiR-24 induces a p53 independent G2-cell cycle arrest.
###end title 14
###begin p 15
###xml 126 132 126 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 152 158 152 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 211 217 211 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 406 412 406 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
(A, B) The bar graphs show the relative quantity of G1/S and G2/S ratio between the non-specific miRNA (negative control) and miR-24 transfected cells. MiR-24 transfection induced a G2-cell cycle arrest. (C, D) miR-24 increases the expression of cell cycle control genes p53 and p21 in HCT 116 (wt-p53) and U-2 OS cells as determined by Western blotting. (E) In p53 null HCT-116 cells, independent of p21, miR-24 inhibited the G2 arrest (B and E).
###end p 15
###begin title 16
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
MiR-24 overexpression affects cell cycle control genes
###end title 16
###begin p 17
###xml 106 107 106 107 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 113 114 113 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Li1">[24]</xref>
###xml 188 194 188 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 330 339 330 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g002">Fig. 2C&#8211;E</xref>
###xml 364 370 364 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 475 482 475 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g002">Fig. 2C</xref>
###xml 485 491 485 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 580 587 580 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g002">Fig. 2D</xref>
###xml 708 718 708 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g002">Fig. 2C, D</xref>
###xml 737 743 737 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 793 799 793 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 893 900 893 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g002">Fig. 2E</xref>
###xml 955 957 955 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">24</italic>
Induction of the p53-dependent cell cycle checkpoint control gene p21 triggers cell cycle arrest at both G1 and G2 phases [24]. To further analyze the cell cycle control genes involved in miR-24 overexpression, we analyzed p53 and p21 expression by immunoblotting in HCT-116 (wt-p53), U-2OS (wt-p53) and HCT-116 cells (null-p53) (Fig. 2C-E). Ectopic expression of miR-24 significantly increased the expression of p53 protein and p21 protein levels in HCT-116 (wt-p53) cells (Fig. 2C). MiR-24 overexpression also induced p53 and p21 expression in the U2-OS osteosarcoma cell line (Fig. 2D). In contrast, a nonspecific-miR (neg) and oligofectamin (oligo) did not cause an increase in expression of p53 or p21 (Fig. 2C, D), suggesting that miR-24-mediated induction of p53 and p21 is specific to miR-24 expression. However, in the HCT-116 cell line that lacked the p53 gene, p21 was not induced (Fig. 2E), indicating that in the absence of p53 function, miR-24 can still induce cell cycle arrest without the involvement of p21.
###end p 17
###begin title 18
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
MiR-24 regulates dihydrofolate reductase, a gene associated with cell proliferation, independent of p53 function
###end title 18
###begin p 19
###xml 105 109 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra3">[25]</xref>
###xml 226 232 226 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra2">[22]</xref>
###xml 289 295 289 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 384 390 384 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 433 439 433 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 574 577 574 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR</italic>
###xml 615 620 615 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">siRNA</italic>
###xml 721 729 721 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g003">Fig 3A&#8211;C</xref>
###xml 750 756 750 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 1078 1084 1078 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 1145 1150 1145 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">siRNA</italic>
###xml 1191 1200 1191 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g003">Fig 3D, E</xref>
###xml 1213 1219 1213 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 216 224 <span type="species:ncbi:9606">patients</span>
DHFR is an S-phase specific enzyme and its levels in the cell are associated with cellular proliferation [25]. Inhibition of DHFR activity by methotrexate affects tumor cell proliferation both in vitro and in cancer patients. MiR-24 has a target site on DHFR 3'-UTR [22]. We reasoned that miR-24-mediated down regulation of DHFR may explain the anti-proliferative effect conferred by miR-24 expression. To confirm this hypothesis, a miR-24 precursor was transfected into cells of varying p53 function: HCT-116 (wt-p53), U2-OS (wt-p53), and HCT-116 (null-p53). A nonspecific miR was used as a negative control. DHFR siRNA was used as a positive control. The expression of DHFR protein was analyzed using Western blotting (Fig 3A-C). Overexpression of miR-24 clearly decreased the expression of DHFR protein, with a potency that was comparable to control DHFR-siRNA, independent of the presence of functional p53. We also analyzed the expression level of DHFR mRNA using real-time qRT-PCR analysis in two cell lines. There was no reduction in DHFR mRNA expression associated with miR-24 overexpression, whereas the decreased expression of DHFR by siRNA was clearly caused by mRNA degradation (Fig 3D, E). Thus, the miR-24 suppression of DHFR expression was most likely regulated at the translational level independent of p53 status.
###end p 19
###begin title 20
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
MiR-24 regulates cell proliferation by regulating DHFR levels, independent of p53 status.
###end title 20
###begin p 21
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A&#8211;C) miR-24</italic>
###xml 599 600 597 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 612 618 610 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
(A-C) miR-24 over-expression down-regulated DHFR protein levels in three cancer cell lines independent of p53 function; in colon cancer HCT 116 (wt-p53) (A), osteosarcoma cell line U2-OS (wt-p53) (B), and HCT-116 (null-p53) cancer cell lines (C). Oligofectamine alone (oligo) and non-specific miRNA (neg) were used as the negative controls. siRNA specific against DHFR (siDHFR) was the positive control. (D-E) The levels of DHFR mRNA in HCT-116 and U-2 OS cells were determined by real time qRT-PCR analysis, GAPDH was used as an internal standard for normalization (data are shown as mean+/-SD. *, P<0.05). (F) miR-24 not only inhibited cell growth but also induced MTX resistance in a HCT-116 colorectal cancer cell line.
###end p 21
###begin title 22
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
MiR-24 overexpression induces methotrexate resistance
###end title 22
###begin p 23
###xml 162 168 162 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 253 259 253 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 377 383 377 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 479 485 479 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 604 608 604 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra2">[22]</xref>
###xml 643 649 643 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 799 805 799 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 825 832 825 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g003">Fig. 3F</xref>
###xml 903 915 903 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s1">introduction</xref>
###xml 929 935 929 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g001">Fig. 1</xref>
###xml 940 941 940 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g004">4</xref>
###xml 1006 1012 1006 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
Generally, MTX treatment inhibits proliferation of rapidly dividing cancer cells without having a limited effect on the proliferation of differentiated cells. As MiR-24 transfection has been shown to induce differentiation in cells, we anticipated that miR-24 overexpression would confer resistance to antiproliferative drugs such as MTX. To test this hypothesis the effect of miR-24 overexpression on MTX resistance was tested. We used HCT-116 (wt-p53) cells transfected with a miR-24 mimic or non-specific miRNA, or siRNA against DHFR. MTX cytotoxicity was performed using previously published methods [22]. We observed that transfection of miR-24 induced MTX resistance in HCT-116 cells, whereas cells transfected with siRNA specific to DHFR or control miRNA were sensitive to MTX as compared to miR-24 transfected cells (Fig. 3F). Since miR-24 overexpression is associated with differentiation (see introduction for detail) (Fig. 1 and 4), we suggest that the slow growth and differentiation caused by miR-24 overexpression contributes to MTX resistance.
###end p 23
###begin title 24
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
Overexpression of miR-24 down regulated DHFR expression, reduced anchorage-dependent growth, and induced morphological changes resembling differentiation.
###end title 24
###begin p 25
###xml 117 123 117 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 143 149 143 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 509 515 509 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 581 587 581 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 1083 1084 1081 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(A) DHFR protein levels were down regulated upon over-expression of DHFR specific siRNA (siDHFR) (by three fold) and miR-24 (by six fold). (B) miR-24 over expression conferred morphological changes that resembled differentiated in a colorectal cancer cell line (HCT-116-wt-p53). The differentiated-like morphological changes were not observed in HCT-116 cells transfected with siDHFR and oligofectamine alone (Cont). (C) Due to a lack of well established differentiation markers, the morphological changes in miR-24 transfected cells were quantitated by light microscopy. Although miR-24 transfection resulted in approximately 70% reduction in cell proliferation, approximately 12% of the total transfected cells, and 38% of total surviving cells, showed a differentiation-like phenotype. (D) Of interest, siRNA specific to DHFR that down regulated DHFR levels in the cells by threefold also reduced anchorage-dependent growth of the HCT-116 colorectal cancer cell line, suggesting that DHFR levels in the cell are associated with cell proliferation (data are shown as mean+/-SD. *, P<0.05).
###end p 25
###begin title 26
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
Overexpression of miR-24 down regulated DHFR expression, reduced anchorage-dependent growth, and induced differentiation-like morphological changes in a colorectal cancer cell line
###end title 26
###begin p 27
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 148 154 148 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 278 285 278 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g004">Fig. 4A</xref>
###xml 557 564 557 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g004">Fig. 4B</xref>
###xml 661 667 661 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 763 767 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra4">[34]</xref>
###xml 778 784 778 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 1014 1021 1014 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g004">Fig. 4C</xref>
###xml 1216 1222 1216 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 1290 1302 1290 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s1">introduction</xref>
###xml 1709 1716 1709 1716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g004">Fig. 4A</xref>
###xml 1833 1840 1833 1840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g004">Fig. 4D</xref>
We quantitated DHFR protein levels, morphological changes, and anchorage-dependent growth upon transfection of a siRNA specific to DHFR and miR-24. MiR-24 overexpression down regulated DHFR levels by approximately six fold as compared to Oligofectamine alone transfected cells (Fig. 4A), and conferred a morphological change resembling a differentiation-like phenotype in a colorectal cancer cell line (HCT-116-wt-p53). The differentiation-like morphological change was not observed in HCT-116 cells transfected with siDHFR and Oligofectamine alone (Cont) (Fig. 4B). Since differentiation markers for colorectal cancer cells are not well established, following miR-24 transfection we used light-microscopy to quantitate the morphological changes in HCT-116 cells [34]. Although miR-24 transfection reduced HCT-116 cell-proliferation by 70% (mostly cytotoxic effect), approximately 12% of the total transfected cells and 38% of the total surviving cells showed morphological changes that resembled differentiation (Fig. 4C). These morphological changes were observed in all six cancer cell lines tested, indicating these were independent of p53 function (data not shown). There are many reports that demonstrate that miR-24 over expression is associated with a differentiated phenotype (see introduction for detail). However, further studies are required to confirm this observation in colorectal cancer cells by well characterizing and establishing differentiation markers, which is an active area of research in the laboratory. Of interest, we also observed that over expression of a DHFR specific siRNA (siDHFR) down-regulated DHFR levels by threefold as compared to Oligofectamine alone transfected cells (Fig. 4A), and also reduced anchorage-dependent growth of the HCT-116 colorectal cancer cell line by approximately two fold (Fig. 4D); these data suggest that changes in DHFR levels are directly associated with cell proliferation.
###end p 27
###begin title 28
###xml 2 8 2 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
A miR-24 target site SNP in dihydrofolate reductase 3'UTR confers an ability on immortalized cells to form foci and growth in anchorage-independent fashion
###end title 28
###begin p 29
###xml 112 118 112 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 145 158 143 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 225 231 223 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 296 302 294 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 496 509 492 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 533 546 529 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 722 726 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra2">[22]</xref>
###xml 781 788 777 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g005">Fig. 5A</xref>
###xml 801 814 797 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 895 905 891 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g005">Fig. 5B, C</xref>
###xml 1033 1040 1029 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g005">Fig. 5B</xref>
###xml 1319 1326 1315 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g005">Fig. 5B</xref>
###xml 1492 1502 1488 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g005">Fig. 5B, C</xref>
DHFR is an S-phase enzyme and its levels are associated with cell proliferation. We demonstrated earlier that a miR-24 target site SNP 829C-->T (miR-24-TS-SNP) in the DHFR 3' UTR results in DHFR overexpression due to loss of miR-24 function (22). We next tested whether cells expressing a mutant miR-24-target site allele (C-->T) that over expresses DHFR provides cells with a growth advantage. CHO DG44 cells were transfected with either DHFR cDNA containing the wt 3'UTR, or DHFR cDNA with the miR-24-TS-SNP in the DHFR 3'UTR. The miR-24-TS-SNP expressing cells had on average a nineteen-fold increase in DHFR mRNA, and four to five fold increase in levels of DHFR protein as compared to wild type DHFR expressing cells [22]. We found that cells overexpressing DHFR (>fourfold) (Fig. 5A) due to the miR-24-TS-SNP in the DHFR gene formed more colonies as compared to wt and vector alone cells (Fig. 5B, C). Of interest, the cells that overexpressed DHFR were morphologically distinct from the wt and the vector alone control cells (Fig. 5B). The colonies formed by the cells with the SNP resembled foci formation in monolayer cultures, characteristic of transformed cells. The wt and vector alone cells that expressed less DHFR grew in a monolayer and morphologically resembled normal DG44 cells under the microscope (Fig. 5B). Contact inhibition was lost in SNP expressing cells, resulting in foci formation with an increase in saturation density as compared to the vector control culture (Fig. 5B, C).
###end p 29
###begin title 30
###xml 19 25 19 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
A loss-of-function miR-24 target site SNP contributes to cellular transformation.
###end title 30
###begin p 31
###xml 8 21 8 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 79 83 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra2">[22]</xref>
###xml 144 150 142 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 454 467 452 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 532 545 530 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 643 651 641 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008445.s002">Table S1</xref>
###xml 809 822 807 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 562 567 <span type="species:ncbi:9606">human</span>
###xml 877 886 <span type="species:ncbi:10090">nude mice</span>
(A) The miR-24-TS-SNP (829C-->T) expressing CHO-DG44 cells over-expressed DHFR [22]. (B-C) DHFR over expression in CHO-DG44 cells due a loss of miR-24 function results in an increase in colony forming ability and (D) show anchorage-independent growth in semi solid agar as compared to vector alone expressing cells (p-value>0.05) (Soft agar colony-forming assay is abbreviated as SAC). (E) Transfection of a siRNA specific to DHFR reduced the ability of miR-24-TS-SNP expressing cells to form soft agar colonies by threefold. (F-H) miR-24-TS-SNP expression in a human cell line - MCF10A (G) and two rodent cell lines - NIH3T3 (H) and RK3 (see Table S1) resulted in more soft agar colony formation as compared to the cells expressing the vector alone and DHFR with wt 3'UTR. (I) DHFR overexpression due to the miR-24-TS-SNP renders NIH3T3 cells tumorigenic when transplanted in nude mice.
###end p 31
###begin p 32
###xml 113 126 113 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 223 236 223 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 485 492 485 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g005">Fig. 5D</xref>
###xml 625 638 625 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 731 744 731 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 834 841 834 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g005">Fig. 5E</xref>
As a second test for the transformed phenotype we used a colony formation assay in soft agar. The ability of wt, miR-24-TS-SNP and vector alone expressing cells to form colonies was tested. We found that the cells with the miR-24-TS-SNP formed more colonies in soft agar and acquired an anchorage-independent phenotype with a six to seven fold increased efficiency as compared with the vector alone cells and three fold more than the cells that overexpressed wt DHFR with a wt 3' UTR (Fig. 5D). Furthermore, to confirm that transformation was due to high levels of DHFR, we next explored the effect of DHFR knock down in the miR-24-TS-SNP expressing cells using a siRNA specific to DHFR. Transfection of the DHFR-specific siRNA in miR-24-TS-SNP expressing cells reduced the soft agar colony forming ability of the cells to threefold (Fig. 5E), suggesting that anchorage independent growth was specific to increased DHFR expression.
###end p 32
###begin p 33
###xml 48 61 48 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 322 335 322 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 615 624 615 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g005">Fig. 5F&#8211;H</xref>
###xml 626 634 626 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008445.s002">Table S1</xref>
###xml 696 709 696 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 165 168 <span type="species:ncbi:10116">rat</span>
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 829 834 <span type="species:ncbi:9606">human</span>
We next tested if overexpressed DHFR due to the miR-24-TS-SNP can also induce anchorage independent growth in two additional rodent cell lines (NIH3T3 cells and RK3-rat kidney cells) and human breast epithelial MCF10A cells, in addition to CHO cells. All three cell line are immortalized but not transformed. The wt DHFR, miR-24-TS-SNP and vector alone constructs were stably transfected into the three cell lines. All three cell lines overexpressing DHFR (>5-fold) formed more colonies in soft agar than the wt-expressing clones. No soft agar colonies were observed in the cells transfected with the vector alone (Fig. 5F-H, Table S1). Therefore, cells transfected with DHFR mRNA containing the miR-24-TS-SNP induced anchorage independent growth in three immortalized rodent cell lines (CHO, NIH3T3 and RK3) and an immortalized human cell line (MCF-10A).
###end p 33
###begin title 34
DHFR overexpression due to the SNP renders NIH3T3 cells tumorigenic in vivo
###end title 34
###begin p 35
###xml 23 36 23 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 354 361 354 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g005">Fig. 5I</xref>
###xml 399 412 399 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 135 144 <span type="species:ncbi:10090">nude mice</span>
###xml 447 456 <span type="species:ncbi:10090">nude mice</span>
We next inoculated the miR-24-TS-SNP expressing NIH3T3 cells and vector alone expressing NIH3T3 cells subcutaneously on to the back of nude mice and tumor formation was monitored. All five animals that were inoculated with the SNP-expressing cells with high DHFR levels (>5-fold) formed tumors, whereas vector alone expressing cells did not form tumors (Fig. 5I). Hence DHFR overexpression due to a miR-24-TS-SNP makes NIH3T3 cells tumorigenic in nude mice.
###end p 35
###begin title 36
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 25 30 <span type="species:ncbi:9606">human</span>
MiR-24 is deregulated in human colorectal cancer tumors and there is a subset of tumors with reduced levels of miR-24
###end title 36
###begin p 37
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Hsu1">[26]</xref>
###xml 97 103 97 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 203 210 203 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008445-g006">Fig. 6A</xref>
###xml 231 237 231 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mir-24</italic>
###xml 521 527 521 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 571 578 571 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
###xml 633 639 633 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 291 299 <span type="species:ncbi:9606">patients</span>
###xml 444 452 <span type="species:ncbi:9606">patients</span>
We investigated miR-expression in normal vs. cancer tissue using miRNAMap-2 [26], and found that miR-24 levels were frequently upregulated in normal but down regulated in cancer cell line/tumor samples (Fig. 6A). Further we tested mir-24 expression in colorectal cancer tumors obtained from patients. Total RNA was isolated from a total of 48 colorectal clinical specimens (24 paired colorectal normal mucosa and tumor samples), collected from patients undergoing surgical resection of primary colorectal adenocarcinoma. MiR-24 levels were determined using q-RT-PCR (see methods for details). Of clinical significance, we found that miR-24 was down regulated in 45% of colorectal cancers as compared to the adjacent normal tissue.
###end p 37
###begin title 38
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 25 30 <span type="species:ncbi:9606">human</span>
MiR-24 is deregulated in human colorectal cancer tumors.
###end title 38
###begin p 39
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 60 64 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Wang1">[20]</xref>
###xml 109 115 109 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 291 299 291 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-1</italic>
###xml 311 319 311 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-2</italic>
###xml 326 332 326 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mir-24</italic>
###xml 370 375 <span type="species:ncbi:9606">human</span>
###xml 467 475 <span type="species:ncbi:9606">patients</span>
(A) We investigated the miR-24 expression, using miRNAMap-2 [20], in normal vs. cancer tissue and found that miR-24 is expression was clearly detectable in normal cell lines/tissues but is down regulated in cancer cell line/tumor samples, as compared to the control cells/tissues (column 1, miR-24-1; column 2, miR-24-2). (B) Mir-24 expression was assayed by Q-RTPCR in human colorectal specimens (24 paired colorectal normal mucosa and tumor samples) collected from patients undergoing surgical resection of primary colorectal adenocarcinoma.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 301 304 301 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra1">[6]</xref>
###xml 341 347 341 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 537 543 537 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 669 675 669 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 848 854 848 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 953 959 953 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 1071 1077 1071 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 1154 1160 1154 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 811 820 <span type="species:ncbi:10090">nude mice</span>
###xml 897 905 <span type="species:ncbi:9606">patients</span>
###xml 918 926 <span type="species:ncbi:9606">patients</span>
Since their discovery in the early 2000s, miRNAs and their ability to regulate gene expression have revolutionized every corner of biological inquiry. Understanding how miRNAs orchestrate oncogenic progression may provide a better understanding of the disease and suggest novel therapeutic approaches [6]. In this report we demonstrate that miR-24, an abundant miRNA that is expressed at high levels in differentiated cells, has an anti-proliferative effect and mediates inhibition of the cell cycle independent of p53 and p21 function. MiR-24 targets DHFR, a gene associated with cell proliferation, independent of p53 function. We demonstrate that a loss of function-miR-24 target site polymorphism in the DHFR 3'UTR induces anchorage-independent growth in vitro and renders immortalized cells tumorigenic in nude mice. Of clinical significance, miR-24 is deregulated in colorectal cancers from patients; 45% of the patients tested had down regulated miR-24 expression in colorectal cancers as compared to the adjacent normal tissue. These data support the notion that miR-24 functions as a p53-independent anti-proliferative miRNA and reexpression of miR-24 may constitute a novel approach to arrest tumor development, at least in part by modulating DHFR expression.
###end p 41
###begin p 42
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra2">[22]</xref>
###xml 263 269 263 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 365 371 365 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 422 435 422 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 491 497 491 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 660 666 660 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 739 752 739 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 868 872 868 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mayr1">[27]</xref>
We previously demonstrated that a loss of miR-24 function polymorphism results in methotrexate resistance as a consequence of increased levels of DHFR mRNA and protein due to loss of translational regulation [22]. Of interest, we observed that over expression of miR-24 rendered cells more resistant to MTX due to reduced cellular proliferation. Over expression of miR-24 may affect expression of other proteins while the miR-24-TS-SNP phenotype has a more DHFR-specific effect. The loss of miR-24 function target site polymorphism that results in DHFR over expression, increased cell proliferation and transformed immortalized cells suggests a novel role for miR-24 as a tumor suppressor miRNA. Alternatively it can be anticipated that a miR-24-TS-SNP that can create miRNA-mediated repression of tumor-suppressor genes may also have an ability to transform the cell [27].
###end p 42
###begin p 43
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mousseau1">[28]</xref>
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Scanlon1">[30]</xref>
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Trimble1">[31]</xref>
###xml 540 544 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-LuckeHuhle1">[32]</xref>
###xml 724 730 724 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 892 896 892 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra3">[25]</xref>
###xml 146 151 <span type="species:ncbi:9606">human</span>
###xml 223 228 <span type="species:ncbi:9606">human</span>
###xml 262 267 <span type="species:ncbi:9606">Human</span>
###xml 515 518 <span type="species:ncbi:10116">rat</span>
DHFR is preferentially synthesized in proliferating cells and is an essential enzyme for DNA synthesis and repair. High DHFR levels were found in human brain tumors, in hypoplastic myelodysplasia and in cisplatin-resistant human colon carcinoma cells [28]-[30]. Human-like DHFR was found to be encoded in Kaposi's sarcoma-associated herpes virus (KSHV), which is known to cause Kaposi's sarcoma and other hematological malignancies [31]. DHFR gene amplification was also correlated with the metastatic potential of rat adenocarcinoma cells [32]. Similarly, our work shows that over expression of DHFR leads to increased cellular proliferation and transformation of immortalized cells, and is regulated, at least in part, by miR-24 miRNA. Transfection of DHFR cDNA and selection of cells with high DHFR levels also transformed immortalized cells in vitro and rendered them tumorigenic in vivo [25].
###end p 43
###begin p 44
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MiR-24</italic>
###xml 328 334 328 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Lal3">[23]</xref>
###xml 505 509 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Lal3">[23]</xref>
###xml 588 594 588 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
MiR-24 regulates the G2/S phase of the cell cycle independent of p53 and p21 function, which in part can be explained by its ability to regulate DHFR translation. However, miRNAs have the ability to up-regulate or down-regulate several essential cellular enzymes and push the cell into cycle. It has been reported recently that miR-24 can suppress the expression of E2F2, Myc and other cell cycle control genes and trigger cell cycle arrest [23]; however cell lines used were either mutant or p53 deleted [23]. In this study, we demonstrate that p21 levels in the cell are increased upon miR-24 overexpression only in the presence of p53.
###end p 44
###begin p 45
###xml 129 135 129 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Lal3">[23]</xref>
###xml 207 213 207 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 257 260 257 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Hammond1">[8]</xref>
###xml 282 288 282 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 404 410 404 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 479 485 479 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 354 362 <span type="species:ncbi:9606">patients</span>
Expression of DHFR in S-phase is required for DNA biosynthesis; this is consistent with the finding that the expression level of miR-24 was high in G1 and G2/M but low in S phase [23]. Deregulations of both miR-24 sites were found to be associated with CLL [8]. We demonstrate that miR-24 levels are deregulated in tumors obtained from colorectal cancer patients. Taken together these data indicate that miR-24 is an important regulator of cell proliferation and reexpression of miR-24 may have therapeutic anticancer value.
###end p 45
###begin p 46
###xml 4 17 4 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24-TS-SNP</italic>
###xml 303 307 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Bertino1">[33]</xref>
###xml 309 313 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra4">[34]</xref>
###xml 518 522 516 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra5">[35]</xref>
###xml 524 528 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra6">[36]</xref>
###xml 681 685 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra6">[36]</xref>
###xml 290 295 <span type="species:ncbi:9606">human</span>
The miR-24-TS-SNP 829C-->T occurs at a 14.2% allelic frequency in the Japanese population, and may predispose cells for cellular transformation following other events in a cell. MiRNA-polymorphisms (miR-polymorphisms or miRSNPs) are a novel class of functional polymorphisms present in the human genome [33], [34]. Cumulative evidences now suggest that genetic variations in miRNAs and are involved in the progression and prognosis of diseases, including neurological disorders and cardiovascular disorders and cancer [35], [36]. By affecting miRNA target function, miR-polymorphisms can potentially affect the expression of several downstream genes and related pathways in a cell [36]. We demonstrate that a loss of miR-24 function-SNP that results in DHFR over expression and MTX resistance, following other events in a cell, can also predispose immortalized cells for transformation. Further inquiry in to related ethnic groups as to its presence, and its effect on treatment outcome and or toxicity will be of importance.
###end p 46
###begin p 47
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 183 189 183 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
In summary we propose a novel role for the miRNA miR-24 as an anti-proliferative miRNA, independent of p53 function, by showing that it targets a pro-proliferation gene DHFR. Loss of miR-24 function, due to a SNP in the 3'UTR of DHFR leads to overexpression of DHFR mRNA and protein and transformation of immortalized cells.
###end p 47
###begin title 48
Materials and Methods
###end title 48
###begin title 49
Ethics Statement
###end title 49
###begin p 50
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient consent was obtained in writing according to institutional regulations. The studies were approved by the Ethics Committee of the University of Ulm (Ulm, Germany) and by the University of Medicine and Dentistry of New Jersey (UMDNJ) Institutional Review Board (IRB) in writing [IRB # 0220080331, written consent was obtained on 1/22/09].
###end p 50
###begin title 51
Cell culture and growth media
###end title 51
###begin p 52
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 130 135 <span type="species:ncbi:9606">human</span>
###xml 373 379 <span type="species:ncbi:9913">bovine</span>
###xml 457 460 <span type="species:ncbi:10116">Rat</span>
###xml 576 582 <span type="species:ncbi:9913">bovine</span>
The human osteosarcoma cell lines U-2 OS, MG63, RKO and HT-29 were obtained from the American Type Culture Collection (ATCC). The human colon cancer cell lines HCT 116 (wt-p53) and HCT 116 (null-p53) were a gift from Professor Bert Vogelstein (The Johns Hopkins University) and were maintained in McCoy's 5A medium (Gibco Laboratories) supplemented with 10% dialyzed fetal bovine serum (HyClone Laboratories). MTX was purchased from Sigma-Aldrich. NIH/3T3, Rat kidney cells (RK3) were purchased from ATCC and grown in Dulbelcco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, 1% l-glutamine (Gibco-BRL).
###end p 52
###begin title 53
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
Transfections of miR-24 and siRNAs
###end title 53
###begin p 54
###xml 76 77 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 148 154 148 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
RKO, HT-29, U2-OS, MG63, HCT-116 (wt-p53) and HCT-116 (null-p53) cells (2x105) were plated in six-well plates and transfected with 100 nM of either miR-24 or non-specific miRNA (Ambion) after 24 h by Oligofectamine (Invitrogen) according to the manufacturer's protocols. siRNA against DHFR was purchased from Dharmacon and transfected with Oligofectamine (Invitrogen) at a final concentration of 100 nM.
###end p 54
###begin title 55
RNA Isolation
###end title 55
###begin p 56
###xml 50 56 50 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
Total RNA, including miRNA, was isolated from the miR-24 transfected cell lines (24 h after transfection) and from clinical colorectal cancer samples using TRIzol reagent, according to the manufacturer's instructions (Invitrogen).
###end p 56
###begin title 57
Real Time qRT-PCR Analysis
###end title 57
###begin p 58
###xml 404 410 404 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 493 494 489 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 494 495 490 491 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 673 674 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 674 675 666 667 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 685 691 677 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 754 755 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 751 756 743 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;dd<italic>C</italic>T</sup>
###xml 764 768 756 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Livak1">[37]</xref>
cDNA synthesis was carried out with the High Capacity cDNA synthesis kit (Applied Biosystems). For mRNA expression the PCR primers and probes for DHFR and internal control gene GAPDH were purchased from Applied Biosystems. Real-time quantitative reverse transcription-PCR (qRT-PCR) analysis was performed on an Applied Biosystems 7500 Real-Time PCR System. The miRNA sequence-specific RT-PCR primers for miR-24 and endogenous control RNU6B were purchased from Ambion. The gene expression DeltaCT values of miRNAs from each clinical sample were calculated by normalizing with internal control RNU6B and relative quantitation values were plotted. Sample with the lowest DeltaCT value of miR-24 was set as 1 to generate relative expression values using 2-ddCT method [37].
###end p 58
###begin title 59
Cell Cycle Analysis
###end title 59
###begin p 60
###xml 68 74 68 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 219 220 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
HCT 116 (wt-p53) and HCT 116 (null-p53) cells were transfected with miR-24 mimic, non-specific miRNA or siRNA against DHFR described as above. At 36 h after transfection, cells were harvested and resuspended at 0.5-1x105 cells/ml in modified Krishan buffer containing 0.1% sodium citrate and 0.3% NP-40 and kept at 4degreesC. Before being analyzed by flow cytometry, cells were treated with 0.02mg/ml RNase H and stained with 0.05mg/ml propidium iodide (Sigma).
###end p 60
###begin title 61
Western blot analysis and antibodies
###end title 61
###begin p 62
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 157 162 <span type="species:ncbi:10090">mouse</span>
###xml 201 206 <span type="species:ncbi:10090">mouse</span>
###xml 236 241 <span type="species:ncbi:10090">mouse</span>
###xml 274 279 <span type="species:ncbi:10090">mouse</span>
At 48 h after transfection with miR-24 mimic or non-specific miRNA, the cells were scraped and lysed in RIPA buffer (Sigma). The primary antibodies included mouse anti-DHFR mAb (1:250, BD Bioscience), mouse anti-p53 mAb (1:1000, DO-1), mouse anti-p21 mAb (1:1000, F-5), and mouse anti-alpha-tubulin mAb (1:1000, TU-02) from Santa Cruz Biotechnology. Oligofectamine alone and non-specific miRNA were used as the negative controls. siRNA against DHFR was used as the positive controls. Bands were quantitated using National Institute of Health's ImageJ software.
###end p 62
###begin title 63
MTX Chemosensitivity
###end title 63
###begin p 64
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 110 116 110 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
HCT 116 (wt-p53) cells were plated in 96-well plates at 1x103 cells/well in triplicate after transfected with miR-24 mimic, non-specific miRNA, or siRNA against DHFR in 100 microl of medium. Twenty-four hours later, MTX in 100 microl medium ranged from 10-200 nM was added, and incubated for 72 h. WST-1 (Roche Applied Science) was added to each well (10 microl). After 2 h incubation, absorbance was measured at 450 and 630 nm respectively. Non-specific miRNA was used as the negative control, and siRNA specific for DHFR was positive controls.
###end p 64
###begin title 65
Cloning and site directed mutagenesis cell transfections and generation of stable clones
###end title 65
###begin p 66
###xml 184 188 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra2">[22]</xref>
###xml 392 396 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Mishra2">[22]</xref>
Wild type DHFR was cloned in a pCDNA3.1 vector and the 829C-->T mutation was created using QuickChange site directed mutagenesis kit (Stratagene, La Jolla, CA) as described previously [22]. The vector alone wt and mutant constructs were transfected into the CHO-DG44, NIH3T3, RK3 and in MCF10A cells. The cells were transfected, selected with G418, and were picked and expanded as cell lines [22].
###end p 66
###begin title 67
Growth, morphological changes and anchorage-independent growth assays
###end title 67
###begin p 68
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 172 178 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 496 500 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Simpson1">[38]</xref>
###xml 562 563 558 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 611 615 607 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Rahman1">[39]</xref>
For cell proliferation analysis on the six cancer cell lines was performed by plating the cells in 96-well plates in triplicate at 1x103 cells/well after transfection with miR-24 mimic, non-specific miRNA, or siRNA against DHFR (n = 3). Cells were cultured for 24, 48, 72, 96 h. The absorbance at 450 and 630 nm was measured after incubation with 10 microl of WST-1 for 2 h. Differentiation-like morphological changes in HCT-116 cells upon miR-24 transfection was quantitated by light-microscopy [38]. Anchorage-independent growth was carried out by plating 5x104 cells per well in 6-well plates in triplicates [39]. After 4-6 weeks incubation the cells were fixed with methanol and acidic acid solution (10%), and stained with ethanol (20%), crystal violet (0.4%); the colonies were scored and large and small colonies were counted. The growth of the clones was assayed by platting 50,000 cells per well in 12-well plates in triplicates and counted at 1-6 days.
###end p 68
###begin title 69
###xml 21 30 <span type="species:ncbi:10090">nude mice</span>
Xenograft studies in nude mice
###end title 69
###begin p 70
###xml 338 343 334 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nu/nu</italic>
###xml 94 103 <span type="species:ncbi:10090">nude mice</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
Tumorigenicity of DHFR over expressing NIH3T3 and RK3 cells was assayed by tumor formation in nude mice. Cells expressing DHFR and vector alone constructs were expanded for two passages without selection. Ten million cells in a total volume of 100microl in growth medium were injected subcutaneously into the backs of 5 to 6-week-old NCR nu/nu mice (Taconic Farms Inc, USA). The growths of tumors were followed three times weekly after the inoculation.
###end p 70
###begin title 71
Clinical Samples
###end title 71
###begin p 72
###xml 749 753 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008445-Xi1">[40]</xref>
###xml 37 44 <span type="species:ncbi:9606">patient</span>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
###xml 580 587 <span type="species:ncbi:9606">Patient</span>
###xml 631 638 <span type="species:ncbi:9606">patient</span>
###xml 712 720 <span type="species:ncbi:9606">patients</span>
A total of 48 snap-frozen colorectal patient specimens were selected (24 paired colorectal normal mucosa and tumor samples). These patients had undergone surgical resection of primary colorectal adenocarcinoma at the Department of Visceral and Transplantation Surgery, University of Ulm, Germany. The colorectal cancer studies were approved by the Ethics Committee of the University of Ulm (Ulm, Germany) and by the University of Medicine and Dentistry of New Jersey (UMDNJ) Institutional Review Board (IRB) in writing [IRB # 0220080331, written consent was obtained on 1/22/09]. Patient consent was obtained in writing from every patient according to the institutional regulations. The characteristics of these patients are described as previously [40]. RNA was isolated using the same method described above (via supra).
###end p 72
###begin title 73
Statistical analysis
###end title 73
###begin p 74
###xml 418 424 418 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">miR-24</italic>
###xml 740 741 738 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
All experiments were repeated at least twice. Statistical significance was evaluated by Student's t test (two tailed) comparison between two groups of data. Asterisks indicate significant differences of experimental groups compared with the corresponding control condition. Statistical analysis was done using GraphPad Prism software (GraphPad, Inc.). Variance ratio test (F-test) was used to compare the variances of miR-24 levels in normal vs cancer tissue. The statistically significant difference in expression level between tumor and normal tissues was calculated using a paired Wilcoxon test, and the statistical analysis was performed by MedCalc(R) 10.0.2 (MedCalc software). Differences were considered statistically significant at p<0.05.
###end p 74
###begin title 75
Supporting Information
###end title 75
###begin p 76
###xml 129 134 <span type="species:ncbi:10090">mouse</span>
###xml 138 144 <span type="species:ncbi:9606">humans</span>
MiR-24 precursor and it's conservation. A) miR-24 stem-loop precursor is shown (B) miR-24 are well conserved among species, from mouse to humans.
###end p 76
###begin p 77
(1.24 MB TIF)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
Anchorage independent growth ability of miRSNP expressing cells in three different cell types.
###end p 79
###begin p 80
(0.03 MB DOC)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin title 82
References
###end title 82
###begin article-title 83
Identification of novel genes coding for small expressed RNAs.
###end article-title 83
###begin article-title 84
###xml 65 87 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans.
###end article-title 84
###begin article-title 85
###xml 36 58 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
An extensive class of small RNAs in Caenorhabditis elegans.
###end article-title 85
###begin article-title 86
Widespread changes in protein synthesis induced by microRNAs.
###end article-title 86
###begin article-title 87
The impact of microRNAs on protein output.
###end article-title 87
###begin article-title 88
MicroRNA reexpression as differentiation therapy in cancer.
###end article-title 88
###begin article-title 89
###xml 23 28 <span type="species:ncbi:9606">human</span>
MicroRNA signatures in human cancers.
###end article-title 89
###begin article-title 90
MicroRNAs as oncogenes.
###end article-title 90
###begin article-title 91
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.
###end article-title 91
###begin article-title 92
###xml 81 86 <span type="species:ncbi:9606">human</span>
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.
###end article-title 92
###begin article-title 93
Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.
###end article-title 93
###begin article-title 94
miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells.
###end article-title 94
###begin article-title 95
Dynamic regulation of miRNA expression in ordered stages of cellular development.
###end article-title 95
###begin article-title 96
Characterization of function and regulation of miR-24-1 and miR-31.
###end article-title 96
###begin article-title 97
###xml 15 20 <span type="species:ncbi:9606">human</span>
Exploration of human miRNA target genes in neuronal differentiation.
###end article-title 97
###begin article-title 98
Initial identification of low temperature and culture stage induction of miRNA expression in suspension CHO-K1 cells.
###end article-title 98
###begin article-title 99
###xml 75 80 <span type="species:ncbi:9606">human</span>
MicroRNA expression patterns and function in endodermal differentiation of human embryonic stem cells.
###end article-title 99
###begin article-title 100
Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.
###end article-title 100
###begin article-title 101
###xml 24 29 <span type="species:ncbi:9606">human</span>
Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis.
###end article-title 101
###begin article-title 102
MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4.
###end article-title 102
###begin article-title 103
p16(INK4a) translation suppressed by miR-24.
###end article-title 103
###begin article-title 104
A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance.
###end article-title 104
###begin article-title 105
miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements.
###end article-title 105
###begin article-title 106
Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
###end article-title 106
###begin article-title 107
Dihydrofolate reductase as an oncogene.
###end article-title 107
###begin article-title 108
miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes.
###end article-title 108
###begin article-title 109
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation.
###end article-title 109
###begin article-title 110
###xml 67 72 <span type="species:ncbi:9606">human</span>
A study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumours.
###end article-title 110
###begin article-title 111
Overexpression of E2F1 Target Gene -DHFR in Hypoplastic Myelodysplasia.
###end article-title 111
###begin article-title 112
###xml 76 81 <span type="species:ncbi:9606">human</span>
Overexpression of DNA replication and repair enzymes in cisplatin-resistant human colon carcinoma HCT8 cells and circumvention by azidothymidine.
###end article-title 112
###begin article-title 113
A gene for dihydrofolate reductase in a herpesvirus.
###end article-title 113
###begin article-title 114
###xml 106 109 <span type="species:ncbi:10116">rat</span>
Permissivity for methotrexate-induced DHFR gene amplification correlates with the metastatic potential of rat adenocarcinoma cells.
###end article-title 114
###begin article-title 115
Pharmacogenomics of microRNA: a miRSNP towards individualized therapy.
###end article-title 115
###begin article-title 116
MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics.
###end article-title 116
###begin article-title 117
MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine.
###end article-title 117
###begin article-title 118
MicroRNA polymorphisms: a giant leap towards personalized medicine.
###end article-title 118
###begin article-title 119
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method.
###end article-title 119
###begin article-title 120
###xml 19 22 <span type="species:ncbi:10116">rat</span>
Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol, Circ.
###end article-title 120
###begin article-title 121
Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme.
###end article-title 121
###begin article-title 122
Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer.
###end article-title 122
###begin p 123
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 123
###begin p 124
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported in part by the Intramural Research Program of the Center of Cancer Research, NCI, NIH; in part by NCI Cancer Research Training Award C5IL039280 (to PJM); in part by Stony-Brook Translational Research Laboratory Start-up fund and NIH CA114043 (to JJ); and in part by NCI Grant CA0810 (to JRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 124

